Ordon Michael, Mnatzakanian Aren, Djuimo Melody, Honey R John D'A, Lee Jason Y
Division of Urology, Department of Surgery, St. Michael's Hospital, Toronto, ON, Canada.
Division of Urology, Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Can Urol Assoc J. 2024 Mar;18(3):E59-E64. doi: 10.5489/cuaj.8507.
At present, there is no literature on the outcomes of robotic-assisted laparoscopic pyeloplasty (RALPyelo) in a Canadian context. Our objective was to perform a retrospective review of RALPyelo cases at a high-volume Canadian center.
We performed a retrospective review of patients who underwent RALPyelo at St. Michael's Hospital, between January 2012 and May 2019. Demographics, operative details, and pre- and postoperative imaging results (ultrasounds, computed tomography [CT] scans, and diuretic renal scan [DRS ]) were recorded. Patients were excluded if at least one-year followup data was unavailable. Our primary outcome was clinical and radiologic improvement defined as 1) symptom improvement; 2) stable/improved split renal function on DRS ; and 3) either improvement in the degree of hydronephrosis on ultrasound or CT, or improved drainage time on DRS. Secondary outcomes included postoperative complications, need for diagnostic intervention, and reintervention for recurrent UPJO.
A total of 156 patients underwent RALPyelo after exclusions. The median age was 42 and 66% were female. Mean followup was 2.5 years. For our primary outcome, 87% had clinical and radiologic improvement. Diagnostic investigation for possible recurrent/persistent obstruction, based on symptoms and/or imaging results, was required in 17% of cases, but only 3% required reintervention for recurrent UPJO. Accordingly, the overall treatment success was 97%. The most common postoperative complication was urinary tract infection (18%), and urine leak was seen in only 2% of patients.
The results of our study compare favorably with currently reported outcomes in the literature and demonstrate the safety and high level of success of RALPyelo at a high-volume Canadian center.
目前,在加拿大背景下,尚无关于机器人辅助腹腔镜肾盂成形术(RALPyelo)结果的文献。我们的目的是对加拿大一家高容量中心的RALPyelo病例进行回顾性研究。
我们对2012年1月至2019年5月在圣迈克尔医院接受RALPyelo的患者进行了回顾性研究。记录了患者的人口统计学信息、手术细节以及术前和术后的影像学结果(超声、计算机断层扫描[CT]和利尿肾图[DRS])。如果没有至少一年的随访数据,则将患者排除。我们的主要结局是临床和影像学改善,定义为:1)症状改善;2)DRS上的分肾功能稳定/改善;3)超声或CT上肾积水程度改善,或DRS上引流时间改善。次要结局包括术后并发症、诊断性干预的需求以及复发性UPJO的再次干预。
排除后,共有156例患者接受了RALPyelo。中位年龄为42岁,66%为女性。平均随访时间为2.5年。对于我们的主要结局,87%的患者有临床和影像学改善。17%的病例基于症状和/或影像学结果需要对可能的复发性/持续性梗阻进行诊断性检查,但只有3%的患者因复发性UPJO需要再次干预。因此,总体治疗成功率为97%。最常见的术后并发症是尿路感染(18%),仅2%的患者出现尿漏。
我们的研究结果与文献中目前报道的结果相比具有优势,并证明了在加拿大一家高容量中心RALPyelo的安全性和高成功率。